Background and First findings

Background and First Findings

Our research team has designed a proprietary software program to identify the Replikin Count™ peptide quantities in other rapidly replicating proteins
- High Replikin Count™ peptide quantities are associated with a variety of infectious agents including HIV, plant viruses, flu viruses, in cases where the agents were associated with rapid replication (i.e., before outbreaks)
- Replikins have been found to be conserved both intrastrain and interstrain as long as 87 years based on data going back to the 1917-18 flu pandemic
The correlation between high Replikin Count™ peptide quantities and major outbreaks of diseases is very high
- Replikin Count™ peptide quantities is increased before strain-specific flu outbreaks
  - The Figure which follows shows the relation of Replikin Count™ peptide quantities to each of the 3 pandemics of the past century
  - This is the first chemistry which correlates with influenza epidemics and pandemics

Recent Press

Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased Boston, November 27, 2009 - Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus... Read more
New Non-Biological Synthetic Replikins™ Vaccines Shown to Be Effective and Fast; WorldVaccines™, Ltd. Formed for Testing and Distribution Old Biological Vaccines for Emergent Diseases - Too Little, Too Late Boston, October 19, 2009 - There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change... Read more